Biliary atresia: A new immunological insight into etiopathogenesis

Expert Review of Gastroenterology and Hepatology

Volumn 3, Issue 6, 2009, Pages 599-606

  Muraji, Toshihiro ^a   Suskind, David L ^b   Irie, Naoki ^c  

^a Ibaraki Children's Hospital   (Japan)

^b UNIVERSITY OF WASHINGTON   (United States)

^c RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

Biliary atresia; CD8+; Cell mediated immunity; Cytokeratin; Graft versus host disease; HLA; Inherited maternal antigen; Inherited paternal antigen; Kasai operation; Maternal microchimerism

Indexed keywords

CYTOKINE; HLA ANTIGEN;

ADAPTIVE IMMUNITY; ALLELE; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE DIFFERENTIATION; BILE DUCT ATRESIA; BILE DUCT OBSTRUCTION; BILIARY CIRRHOSIS; CELL DAMAGE; CELLULAR IMMUNITY; CHOLANGIOGRAPHY; CHOLESTASIS; CLINICAL FEATURE; CONGENITAL MALFORMATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EMBRYO DEVELOPMENT; EPITHELIUM CELL; ETHNICITY; FETUS DEVELOPMENT; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; HEPATIC DUCT; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; LIVER DEVELOPMENT; LIVER HILUS; LIVER INJURY; MICROCHIMERISM; NONHUMAN; PHENOTYPE; PORTAL HYPERTENSION; PROTEIN FUNCTION; REVIEW; VIRUS INFECTION; X CHROMOSOME; Y CHROMOSOME;

ANTIGEN-PRESENTING CELLS; BILIARY ATRESIA; CHIMERISM; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNITY, CELLULAR; LINKAGE DISEQUILIBRIUM; MATERNAL-FETAL EXCHANGE; PREGNANCY;

EID: 73449148740     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.09.61     Document Type: Review

References (60)

1. Shim WK, Kasai M, Spence MA et al. Racial influence on the incidence of biliary atresia. Prog. Pediatr. Surg. 6, 53-62 (1974).
2. Sokol RJ, Mack C, Narkewicz MR et al. Pathogenesis and outcome of biliary atresia:current concepts. J. Pediatr. Gastro. Nutr. 37, 4-21(2003).
3. Hays DM, Snyder WH Jr. Life span in untreated biliary atresia. Surgery 54, 373-375 (1963).
4. Muraji T, Nio M, Ohhama Y et al. Postoperative corticosteroid therapy for bile drainage in biliary atresia - a nationwide survey. J. Pediatr. Surg. 39(12), 1803-1805 (2004).
5. Shneider BL, Brown B, Haber PF et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J. Pediatr. Surg. 148(4), 467-474 (2006).
6. Redkar R, Davenport M, Howard ER et al. Antenatal diagnosis of congenital anomalies of the biliary tract. J. Pediatr. Surg. 33, 700-704 (1998).
7. Schweizer P, Petersen M, Jeszberger N et al. Immunohistochemical and molecular biological investigations regarding the pathogenesis of extrahepatic biliary atresia. Eur. J. Pediatr. Surg. 13, 7-15 (2003).
8. Ohya T, Fujimoto T, Shimomura H et al. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J. Pediatr. Surg. 30, 515-518 (1995).
9. Weerascooriya VS, White FR, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J. Pediatr. 144, 123-125 (2004).
10. Sokol RJ, Mack C. Etiopathogenesis of biliary atresia. Sem. Liver Dis. 21, 517-524 (2001).
11. Davenport M, Tizzard SA, Underhill J et al. The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J. Pediatr. 149, 393-400 (2006).
12. Landing BH. Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst; the concept of infantile obstructive cholangiopathy. Prog. Pediatr. Surg. 6, 113-139(1974).
13. Hadchouel, Hugon RN, Odievre M. Immunoglobulin deposits in the biliary remnants of extrahepatic biliary atresia: a study by immunoperoxidase staining in 128 infants. Histopathology 5, 217-221 (1981).
14. Balistreri WF, Grand R, Hoofnagle JH et al. Biliary atresia: current concepts and research directions. Hepatology 23(6), 1682-1692 (1996).
15. Schreiber RA, Kleinmam RE. Genetics, immunology, and biliary atresia: an opening or a diversion? J. Pediatr. Gastro. Nutr. 16, 111-113 (1993).
16. Riepenhoff-Talty M, Schaekel K, Clark HF et al. Group A rotavirus produce extrahepatic biliary obstruction inorally inoculated newborn mice. Pediatr. Res. 33, 394-399 (1993) .
17. Czech-Schmidt G, Verhagen W, Szavay P et al. Immunological gap in the infectious animal model for biliary atresia. J. Surg. Res. 101, 62-67 (2001).
18. Petersen C. Pathogenesis and treatment opportunities for biliary atresia. Clin. Liver Dis. 10, 73-88 (2006).
19. Landing BH, Yutuc IL, Swanson VL. Clinicopathologic correlations in immunologic deficiency diseases of children, with emphasis on thymic histologic patterns. In: Proceedings of the International Symposium on Immunodeficiency. Japan Medical Research Foundation, Japan, 15-17 (1976). Valuable description that patients with biliary atresia (BA) have a possible defect or aftermath of immunological abnormality. Additional validations are awaited.
20. Muraji T, Hashimoto K, Ifuku H et al. Increased expression of HLA-DR antigen on biliary epithelium cells in biliary atresia. J. Jpn. Soci. Pediatr. Surg. 24, 793-796 (1988).
21. Kobayashi H, Puri P, O'Brian S et al. Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis. J. Pediatr. Surg. 32, 590-593 (1997).
22. Davenport M, Gonde C, Redkar R et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J. Pediatr. Surg. 36, 1017-1025 (2001).
23. Reynoso-Paz S, Coppel RL et al. The immunobiology of bile and biliary epithelium. Hepatology 30(2), 351-357 (1999).
24. Dillon P, Belchis D, Tracy T et al. Increased expression of intercellular adhesion molecules in biliary atresia. Am. J. Pathol. 145, 263-267 (1994).
25. Leon MP, Bassendine MF et al. Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology 112, 968-977 (1997).
26. Kobayashi H, Horikoshi K, Long L et al. Serum concentration of adhesion molecules in postoperative biliary atresia patients: relationship to disease activity and cirrhosis. J. Pediatr. Surg. 36, 1297-1301 (2001).
27. Kobayashi H, Li Z, Yamataka A et al. Role of immunologic costimulatory factors in the pathogenesis of biliary atresia. J. Pediatr. Surg. 38, 892-896 (2003).
28. Ahmed AFKU, Ohtani H, Nio M et al. Intrahepatic mast cell population correlates with clinical outcome in biliary atresia. J. Pediatr. Surg. 35, 1762-1765 (2000).
29. Liu C, Chiu JH, Wang LS et al. Expression of Fas ligand on bile ductile epithelium in biliary atresia - a poor prognostic factor. J. Pediatr. Surg. 35, 1591-1596 (2000).
30. Funaki N, Sasano H, Shizawa S et al. Apoptosis and cell proliferation in biliary atresia. J. Pathol. 186, 429-433 (1998).
31. +Th1 cell-mediated portal tract inflammation. Pediatr. Res. 56, 79-87 (2004).
32. + T cells in bilary atresia. J. Pediatr. Surg. 41, 300-305 (2006).
33. +lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology 133, 268-277 (2007).
34. Suskind DL, Rosentahl P, Heyman MB et al. Maternal microchimerism in the livers of patients with biliary atresia. BMC Gastroenterology 4, 14 (2004).
35. Kobayashi H, Tamatani T, Tamura T et al. Maternal microchimerism in biliary atresia. J. Pediatr. Surg. 42, 987-991 (2007).
36. Hayashida M, Nishimoto Y, Matsuura T et al. The evidence of maternal microchimerism in biliary atresia using in situ hybridization. J. Pediatr. Surg. 42, 2097-2101 (2007).
37. Muraji T, Hosaka N, Irie N et al. Maternal microchmerism in underlying pathogenesis of biliary atresia: quantification and phenotypes of maternal cells in the liver. Pediatrics 121, 517-521 (2008). First report of the quantification and phenotype determination of maternal chimeric cells existing in the liver of pwaitihe nBtAs .
38. Susanna M, Ege M, Pottharst A et al. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 98, 1847-1851 (2001). Important in that patients with severe combined immunodeficiency disease (SCID) clinically showed the graft-versushost disease (GvHD) occurring due to transplacentally engrafted maternal cells, supporting the possibility of GvHD as the cause of BA.
39. Nonomura A, Kono N, Mizukami Y et al. Histological changes of the liver in experimental graft-versus-host disease across minor histocompatibility barriers. VII A light and electron microscopic sudy of the large bile duct. Liver 13, 163-171 (1993) Report of animal models of GvHD across minor histocompatibility that develop biliary epithelial damage of the extrahepatic bile ducts.
40. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266-271 (2004).
41. West LJ. Defining critical windows in the development of the human immune system. Hum. Exp. Toxicol. 21, 499-505 (2002). Updates the information about the critical windows in the development of the human immune system, which will provide basic knowledge about when to consider the possible timing of the insult causing BA.
42. Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation". Hepatology 16, 1070-1083 (1992).
43. Holt OG, Jones CA, The development of the immune system during pregnancy and early life. Allergy 55, 688-697 (2000).
44. Mold JE, Michaelsson J, Burt TD et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322, 1562-1565 (2008).
45. A-Kader HH, El-Ayyouti M, Hawas S et al. HLA in Egyptian children with biliary atresia. J. Pediatr. 141(3), 432-433 (2002). First documentation of maternal HLA class II compatibility in men with systemic lupus erythematosis.
46. Yuasa T, Tsuji H, Kimura S et al. Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantation. Hum. Immunol. 66, 295-300 (2005).
47. Berry SM, Hassan SS, Russell E et al. Association of maternal histocompatibility at class II HLA loci with maternal microchimerism in the fetus. Pediatr. Res. 56(1), 73-78 (2004).
48. Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351, 559-562 (1998).
49. Stevens AM, Tsao BP, Hahn BH et al. Maternal HLA class II compatibility in men with systemic lupus erythematosis. Arth. Rheumat. 52, 2768-2772 (2005).
50. Irie N, Muraji, T, Hosaka N et al. Maternal HLA class I compatibility in patients with biliary atresia. J. Pediatr. Gastro. Nutr. 49, 488-492(2009). First work to suggest patients with BA have an immunogenetically biased relationship against their mothers.
51. The data of nation-wide survey of biliary atresia in 2004. J. Jap. Soc. Pediatr. Surg. 42, 287-294 (2006).
52. Chardot C, Caton M, Spire-Bendelac N et al. Epidemiology of biliary atresia in France: a national study 1986-1996. J. Hepatol. 31, 1006-1013 (1999).
53. Livesey E, Cortina BM, Sharif K et al. Epidemiology of biliary atresia in England and Wales (1999-2006). Arch. Dis. Child. Fetal Neonatal Ed. DOI: 10.1136/ adc.2009.159780 19 (2009) (Epub ahead of print).
54. Hsiao CH, Chang MH, Lee HC et al. Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology 47, 1105-1107 (2008).
55. Hyams JS, Glaser JH, Leichtner AM, Morecki R. Discordance for biliary atresia in two sets of monozygotic twins. J. Pediatr. 107(3), 420-422 (1985).
56. Schweizer P, Kerremans J. Discordant findings in extrahepatic bile duct atresia in 6 sets of twins. Z. Kinderchir. 43(2), 72-75 (1988).
57. Arlett CM, Ramos R, Jimenez SA et al. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet 356, 2155-2156 (2000).
58. Reed AM, Picomell YJ, Harwood A et al. Chimerism in children with juvenile dermatomyositis. Lancet 356, 2156-2157 (2000).
59. Stevens AM, Hermes HM, Rutledge JC et al. Myocardial-tissue- specific phenotype of maternal microchimrism in neonatal lupus congenital heart block. Lancet 362, 1617-1623 (2003).
60. Ichinohe T, Teshima T, Matsuoka K, Maruya E, Saji H. Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation. Curr. Opin. Immunol. 17(5), 546-552 (2005).